Chemopreventive effect of different ratios of fish oil and corn oil on prognostic markers, DNA damage and cell cycle in colon carcinogenesis

European Journal of Cancer Prevention

Volumn 21, Issue 2, 2012, Pages 147-154

  Sarotra, Pooja ^a   Kansal, Shevali ^a   Sandhir, Rajat ^a   Agnihotri, Navneet ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Cell cycle; Colon cancer; Corn oil; DNA damage; Fish oil; n 3 polyunsaturated fatty acid; p53

Indexed keywords

1,2 DIMETHYLHYDRAZINE; APURINIC ACID; CORN OIL; CYCLIN D1; FISH OIL; PROTEIN P53; SIALIC ACID; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APYRIMIDINIC SITE; ARTICLE; BODY WEIGHT; CANCER PROGNOSIS; CELL CYCLE; CELL PROLIFERATION; CELL VIABILITY; CELLS; CHEMOPROPHYLAXIS; COLON CARCINOGENESIS; COLONOCYTE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; DIETARY INTAKE; DNA DAMAGE; FLOW CYTOMETRY; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT DURATION;

ANIMALS; CARCINOMA; CELL CYCLE; CELLS, CULTURED; CHEMOPREVENTION; COLONIC NEOPLASMS; CORN OIL; DIETARY FATS; DNA DAMAGE; EATING; FISH OILS; MALE; OSMOLAR CONCENTRATION; PROGNOSIS; RATS; RATS, WISTAR; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84858281151     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32834c9bfb     Document Type: Article

References (49)

1. Alao JP (2007). The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer 6:24.
2. Aranganathan S, Selvam JP, Nalini N (2009). Hesperetin exerts dose dependent chemopreventive effect against 1,2-dimethyl hydrazine induced rat colon carcinogenesis. Invest New Drugs 27:203-213.
3. Bancroft LK, Lupton JR, Davidson LA, Taddeo SS, Murphy ME, Carroll RJ, et al. (2003). Dietary fish oil reduces oxidative DNA damage in rat colonocytes. Free Radic Biol Med 35:149-159. (Pubitemid 36835915)
4. Chen ZY, Istfan NW (2001). Docosahexaenoic acid, a major constituent of fish oil diets, prevents activation of cyclin dependent kinases and S-phase entry by serum stimulation in HT-29 cells. Prostaglandins Leukot Essent Fatty Acids 64:67-73.
5. Clandinin MT, Cheema S, Pehowich D, Field CJ (1996). Effect of polyunsaturated fatty acids in obese mice. Lipids 31:13-22.
6. De Moraes E, Dar NA, de Moura Gallo CV, Hainaut P (2007). Cross-talks between cyclooxygenase-2 and tumor suppressor protein p53: balancing life and death during inflammatory stress and carcinogenesis. Int J Cancer 121:929-937. (Pubitemid 47101627)
7. El-Aziz MA, Hassan HA, Mohamed MH, Meki AR, Abdel-Ghaffar SK, Hussein MR (2005). The biochemical and morphological alterations following administration of melatonin, retinoic acid and Nigella sativa in mammary carcinoma: an animal model. Int J Exp Pathol 86:383-396. (Pubitemid 41746377)
8. Elnenaei MO, Jadayel DM, Matutes E, Morilla R, Owusu-Ankomah K, Atkinson S, et al. (2001). Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies. Leuk Res 25:115-123. (Pubitemid 32141114)
9. Fearon KC, Barber MD, Moses AG, Ahmedzai SH, Taylor GS, Tisdale MJ, et al. (2006). Double blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol 24:3401-3407. (Pubitemid 46638896)
10. Freshney RI (1994). Culture of Animal Cells: A Manual of Basic Technique. 1994: New York: Wiley-Liss Press. pp. 287-307.
11. Gallus S, Bosetti C, Vecchia C (2004). Mediterranean diet and cancer risk. Eur J Cancer prev 13:447-452. (Pubitemid 39336610)
12. Hail N Jr, Cortes M, Drake EN, Spallholz JE (2008). Cancer chemoprevention: a radical perspective. Free Radic Biol Med 45:97-110.
13. Hainaut P, Hollstein M (2000). p53 and human cancer: the first ten thousand mutations. Adv Cancer Res 77:81-137. (Pubitemid 29439303)
14. Hamelin R, Laurent-Puig P, Olschwang S, Jego N, Asselain B, Remvikos Y, et al. (1994). Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 106:42-48. (Pubitemid 24011863)
15. Hsieh TC, Wu JM (1999). Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp Cell Res 249:109-115.
16. Iannone F, De Bari C, Scioscia C, Patella V, Lapadula G (2005). Increased Bcl-2/p53 ratio in human osteoarthritic cartilage: a possible role in regulation of chondrocyte metabolism. Ann Rheum Dis 64:217-221. (Pubitemid 40193615)
17. Iggo R, Gatter K, Bartek J, Lane D, Harris AL (1990). Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335:675-679. (Pubitemid 20089305)
18. Ishii Y, Pirkmaier A, Alvarez JV, Frank DA, Keselman I, Logothetis D, et al. (2006). Cyclin D1 over expression and response to bortezomib treatment in a breast cancer model. J Natl Cancer Inst 98:1238-1247. (Pubitemid 44390994)
19. Jackson PE, O'Connor PJ, Cooper DP, Margison GP, Povey AC (2003). Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine. Carcinogenesis 24:527-533. (Pubitemid 36432649)
20. Jain SK, Peppercorn MA (1997). Inflammatory bowel disease and colon cancer: a review. Dig Dis 15:243-252. (Pubitemid 127522066)
21. Jemal A, Siegel R,Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin 2009; 59:225-249.
22. Kanwar SS, Vaiphei K, Nehru B, Sanyal SN (2007). Chemopreventive effects of non-steroidal anti-inflammatory drugs in the membrane lipid composition and fluidity parameters of the 1,2 dimethyl hydrazine induced colon carcinogenesis in rats. Drug Chem Toxicol 30:293-309. (Pubitemid 47575040)
23. Katopodis N, Hirshaut Y, Geller NL, Stock CC (1982). Lipid-associated sialic acid test for detection of human cancer. Cancer Res 42:5270-5275. (Pubitemid 13223181)
24. Kikuchi-Yanoshita R, Konishi M, Ito S, Seki M, Tanaka K, Maeda Y, et al. (1992). Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and nonfamilial adenomatous polyposis patients. Cancer Res 52:3965-39671.
25. Kokoglu E, Sonmez H, Uslu E, Uslu I (1992). Sialic acid levels in various types of cancer. Cancer Biochem Biophys 13:57-64.
26. Latham P, Lund EK, Johnson IT (1999). Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon. Carcinogenesis 20:645-650. (Pubitemid 29151302)
27. Menendez JA, Lupu R, Colomer R (2005). Exogenous supplementation with [omega]-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells. Eur J Cancer prev 14:263-270. (Pubitemid 40789954)
28. Musgrove EA (2006). Cyclins: roles in mitogenic signaling and oncogenic transformation. Growth Factors 24:13-19.
29. Oliveria SA, Christos PJ, Berwick M (1997). The role of epidemiology in cancer prevention. Proc Soc Exp Biol Med 216:142-150.
30. Patil JR, Jayaprakasha GK, Murthy KNC, Tichy SE, Chetti MB, Patil BS (2009). Apoptosis-mediated proliferation inhibition of human colon cancer cells by volatile principles of Citrus aurantifolia. Food Chem 114:1351-1358.
31. Plucinsky MC, Riley WM, Prorok JJ, Alhadeff JA (1986). Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement. Cancer 58:2680-2685. (Pubitemid 17232928)
32. Polivkova J, Vosmikova K, Horak L (1992). Utilization of determining lipid-bound sialic acid for the diagnosis and further prognosis of cancer. Neoplasma 39:233-236.
33. Reddy BS (1994). Chemoprevention of colon cancer by dietary fatty acids. Cancer Metastasis Rev 13:285-302.
34. Saini MK, Kaur J, Sharma P, Sanyal SN (2009). Chemopreventive response of diclofenac, a non-steroidal anti-inflammatory drug, in experimental carcinogenesis. Nutr Hosp 24:717-723.
35. Sanders LM, Henderson CE, Hong MY, Barhoumi R, Burghardt RC, Wang N, et al. (2004). An increase in reactive oxygen species by dietary fish oil coupled with the attenuation of antioxidant defenses by dietary pectin enhances rat colonocyte apoptosis. J Nutr 134:3233-3238. (Pubitemid 39602991)
36. Sansom OJ, Reed KR, van de Wetering M, Muncan DJ, Clevers H, Clarke AR (2005). Cyclin D1 is not an immediate target of β-catenin following Apc loss in the intestine. J Biol Chem 280:28463-28467. (Pubitemid 41105745)
37. Sarotra P, Sharma G, Kansal S, Negi AK, Aggarwal R, Sandhir R, et al. (2010). Chemopreventive effect of different ratios of fish oil and corn oil in experimental colon carcinogenesis. Lipids 45:785-798.
38. Schut HAJ,Wang CL, Twining LM, Earle KM (1997). Formation and persistence of DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in CDF1 mice fed a high n-3 fatty acid diet. Mutat Res 378:23-30. (Pubitemid 27342081)
39. Sharma P, Kaur J, Sanyal SN (2010). Effect of etoricoxib, a cyclooxygenase-2 selective inhibitor, on aberrant crypt formation and apoptosis in 1,2-dimethyl hydrazine induced colon carcinogenesis in rat model. Nutr Hosp 25:39-48.
40. Shin DM, Xu XC, Lippman SM, Lee JJ, Lee JS, Batsakis JG, et al. (1997). Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention. Clin Cancer Res 3:875-880. (Pubitemid 27252935)
41. Sikorsky JA, Primerano DA, Fenger TW, Denvir J (2007). DNA damage reduces Taq DNA polymerase fidelity and PCR amplification efficiency. Biochem Biophys Res Commun 355:431-437. (Pubitemid 46282646)
42. Simopoulos AP (1999). Essential fatty acids in health and chronic disease. Am J Clin Nutr 70:560S-569S.
43. Singh NP, McCoy MT, Tice RR, Schneider EL (1998). A simple technique for quantification of low levels of DNA damage in individual cells. Exp Cell Res 175:184-191.
44. Srivastava S, Verma M, Henson DE (2001). Biomarkers for early detection of colon cancer. Clin Cancer Res 7:1118-1126. (Pubitemid 32708660)
45. Stoyloff J, Ivanov S (2010). Isolation and characterization of galactose-specific carbohydrate-binding protein from guerin tumor cells. Brain Res Bull 83:65-75.
46. Takahashi M, Fukutake M, Isoi T, Fukuda K, Sato H, Yazawa K, et al. (1997). Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA). Carcinogenesis 18:1337-1342. (Pubitemid 28134706)
47. Tanwar L, Vaish V, Sanyal SN (2010). Chemopreventive role of etoricoxib (MK-0663) in experimental colon cancer: induction of mitochondrial proapoptotic factors. Eur J Cancer Prev 19:280-287.
48. Veena K, Shanthi P, Sachdanandam P (2006). Anticancer effect of kalpaamruthaa on mammary carcinoma in rats with reference to glycoprotein components, lysosomal and marker enzymes. Biol Pharm Bull 29:565-569.
49. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. (1988). Genetic alterations during colorectal tumor development. N Engl J Med 319:525-532.